Invention Grant
- Patent Title: Adenosine receptor modulators for the treatment of circadian rhythm disorders
-
Application No.: US16912143Application Date: 2020-06-25
-
Publication No.: US11931374B2Publication Date: 2024-03-19
- Inventor: Sridhar Vasudevan , Aarti Jagannath , Russell Foster
- Applicant: OXFORD UNIVERSITY INNOVATION LIMITED
- Applicant Address: GB Oxford
- Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
- Current Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
- Current Assignee Address: GB Oxford
- Agency: Chalker Flores, LLp
- Agent Edwin S. Flores; Daniel J. Chalker
- Priority: GB 06622 2016.04.15
- Main IPC: A61K31/53
- IPC: A61K31/53 ; A61K31/44 ; A61K31/4418 ; A61K31/4439 ; A61K31/505 ; A61K31/517 ; A61K31/519 ; A61K31/522 ; A61K31/5377 ; A61K31/7076 ; A61P25/00
Abstract:
The present invention relates to the use of adenosine receptor modulators to affect the circadian rhythm, in particular, to the use of such modulators for the treatment of circadian rhythm disorders. In particular, the invention relates to a composition comprising at least one selective adenosine receptor modulator, wherein said composition modulates two or three, but not all of adenosine receptor subtypes A1, A2A, A2B and/or A3 for use in the treatment of circadian rhythm disorders or for modulating a biological clock.
Public/Granted literature
- US20210106605A1 Adenosine Receptor Modulators for the Treatment of Circadian Rhythm Disorders Public/Granted day:2021-04-15
Information query
